Mesenchymal stem cells: biological properties and clinical applications

Bibliography

• Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 1970;3:393-403
   PubMedGoogle Scholar
• Caplan AI. Mesenchymal stem cells. J Orthop Res 1991;9:641-50
   PubMed Web of Science ®Google Scholar
• Pittenger MF, Mackay AM, Beck SC, Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-7
   PubMed Web of Science ®Google Scholar
• Alejandro E, Paulette C, Jose JM. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 2000;109:235-42
   PubMed Web of Science ®Google Scholar
• Donald GP, Darwin JP. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair – current views. Stem Cells 2007;25:2896-902
   PubMed Web of Science ®Google Scholar
• Gronthos S, Mankani M, Brahim J, Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci USA 2000;97:13625-30
   PubMed Web of Science ®Google Scholar
• Williams JT, Southerland SS, Souza J, Cells isolated from adult human skeletal muscle capable of differentiating into multiple mesodermal phenotypes. Am Surg 1999;65:22-6
   PubMed Web of Science ®Google Scholar
• Zuk PA, Zhu M, Ashjian P, Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002;13:4279-95
   PubMed Web of Science ®Google Scholar
• Horwitz EM, Le Blanc K, Dominici M, Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement. Cytotherapy 2005;7:393-5
   PubMed Web of Science ®Google Scholar
• Gronthos S, Zannettino AC, Hay SJ, Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J Cell Sci 2003;116:1827-35
   PubMed Web of Science ®Google Scholar
• D'Ippolito G, Diabira S, Howard GA, Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J Cell Sci 2004;117:2971-81
   PubMed Web of Science ®Google Scholar
• Reyes M, Lund T, Lenvik T, Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood 2001;98:2615-25
   PubMed Web of Science ®Google Scholar
• Crisan M, Yap S, Casteilla L, A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008;3:301-13
   PubMed Web of Science ®Google Scholar
• da Silva Meirelles L, Caplan AI, Nardi NB. In search of the in vivo identity of mesenchymal stem cells. Stem Cells 2008;26:2287-99
   PubMed Web of Science ®Google Scholar
• Takashima Y, Era T, Nakao K, Neuroepithelial cells supply an initial transient wave of MSC differentiation. Cell 2007;129:1377-88
   PubMed Web of Science ®Google Scholar
• Dominici M, Le Blanc K, Mueller I, Minimal criteria for defining multipotent mesenchymal stromal cells. the International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315-17
   PubMed Web of Science ®Google Scholar
• Campagnoli C, Roberts IA, Kumar S, Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 2001;98(8):2396-402
   PubMed Web of Science ®Google Scholar
• Tatiana T, Nathalie M, Alain D, Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity. Stem Cells 2005;23:1105-12
   PubMed Web of Science ®Google Scholar
• Kolf C, Cho E, Tuan R. Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res Ther 2007;9(1):204
   PubMed Web of Science ®Google Scholar
• Lin G, Garcia M, Ning H, Defining stem and progenitor cells within adipose tissue. Stem Cells Dev 2008;17(6):1053-64
   PubMed Web of Science ®Google Scholar
• Yanez R, Lamana ML, Garcia-Castro J, Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease. Stem Cells 2006;24(11):2582-91
   PubMed Web of Science ®Google Scholar
• Simmons PJ, Torok-Storb B. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 1991;78:55-62
   PubMed Web of Science ®Google Scholar
• Eliopoulos N, Stagg J, Lejeune L, Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice. Blood 2005;106:4057-65
   PubMed Web of Science ®Google Scholar
• Chen L, Tredget EE, Liu C, Wu Y. Analysis of allogenicity of mesenchymal stem cells in engraftment and wound healing in mice. PLoS ONE 2009;4(9):e7119
   Google Scholar
• Rasmusson I, Ringden O, Sundberg B, Le Blanc K. Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms. Exp Cell Res 2005;305:33-41
   PubMed Web of Science ®Google Scholar
• Larghero J, Vija L, Lecourt S, Mesenchymal stem cells and immunomodulation: toward new immunosuppressive strategies for the treatment of autoimmune diseases? Rev Med Interne 2009;2030:287-99
   Web of Science ®Google Scholar
• Meisel R, Zibert A, Laryea M, Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 2004;103:4619-21
   PubMed Web of Science ®Google Scholar
• Nasef A, Mathieu N, Chapel A, Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G. Transplantation 2007;84(2):231-7
   PubMed Web of Science ®Google Scholar
• Sato K, Ozaki K, Oh I, Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood 2007;109:228-34
   PubMed Web of Science ®Google Scholar
• Gieseke F, Schutt B, Viebahn S, Human multipotent mesenchymal stromal cells inhibit proliferation of PBMCs independently of IFNgammaR1 signaling and IDO expression. Blood 2007;110:2197-200
   PubMed Web of Science ®Google Scholar
• Beyth S, Borovsky Z, Mevorach D, Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 2005;105:2214-19
   PubMed Web of Science ®Google Scholar
• Djouad F, Plence P, Bony C, Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 2003;102:3837-44
   PubMed Web of Science ®Google Scholar
• Maccario R, Podesta M, Moretta A, Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype. Haematologica 2005;90:516-25
   PubMed Web of Science ®Google Scholar
• Glennie S, Soeiro I, Dyson PJ, Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 2005;105:2821-7
   PubMed Web of Science ®Google Scholar
• Deng W, Han Q, Liao L, Effects of allogeneic bone marrow-derived mesenchymal stem cells on T and B lymphocytes from BXSB mice. DNA Cell Biol 2005;24:458-63
   PubMed Web of Science ®Google Scholar
• Rasmusson I, Blanc KL, Sundberg B, Ringden O. Mesenchymal stem cells stimulate antibody secretion in human B cells. Scand J Immunol 2007;65:336-43
   PubMed Web of Science ®Google Scholar
• Corcione A, Benvenuto F, Ferretti E, Human mesenchymal stem cells modulate B-cell functions. Blood 2006;107:367-72
   PubMed Web of Science ®Google Scholar
• Panagiota AS, Sonia AP, Angelos DG, Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells 2006;24:74-85
   PubMed Web of Science ®Google Scholar
• Krampera M, Cosmi L, Angeli R, Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 2006;24:386-98
   PubMed Web of Science ®Google Scholar
• Rasmusson I, Ringden O, Sundberg B, Le Blanc K. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation 2003;76:1208-13
   PubMed Web of Science ®Google Scholar
• Le Blanc K. Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy 2003;5(6):485-9
   PubMed Web of Science ®Google Scholar
• Spaggiari GM, Capobianco A, Becchetti S, Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 2006;107:1484-90
   PubMed Web of Science ®Google Scholar
• Li Y-P, Paczesny S, Lauret E, Human mesenchymal stem cells license adult CD34+ hemopoietic progenitor cells to differentiate into regulatory dendritic cells through activation of the notch pathway. J Immunol 2008;180:1598-608
   PubMed Web of Science ®Google Scholar
• Farida D, Louis-Marie C, Carine B, Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism. Stem Cells 2007;25:2025-32
   PubMed Web of Science ®Google Scholar
• Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005;105:1815-22
   PubMed Web of Science ®Google Scholar
• Nemeth K, Leelahavanichkul A, Yuen PST, Bone marrow stromal cells attenuate sepsis via prostaglandin E2-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 2009;15:42-9
   PubMed Web of Science ®Google Scholar
• Kim J, Hematti P. Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages. Exp Hematol 2009;37:1445-53
   PubMed Web of Science ®Google Scholar
• Lingyun S, Kentaro A, Huayong Z, Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans. Stem Cells 2009;27:1421-32
   PubMed Web of Science ®Google Scholar
• Djouad F, Fritz V, Apparailly F, Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis. Arthritis Rheum 2005;52:1595-603
   PubMed Web of Science ®Google Scholar
• Gerdoni E, Gallo B, Casazza S, Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Annals Neurol 2007;61:219-27
   PubMed Web of Science ®Google Scholar
• Augello A, Tasso R, Negrini SM, Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis. Arthritis Rheum 2007;56:1175-86
   PubMed Web of Science ®Google Scholar
• Stagg J, Pommey S, Eliopoulos N, Galipeau J. Interferon-gamma-stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cell. Blood 2006;107:2570-7
   PubMed Web of Science ®Google Scholar
• Honczarenko M, Le Y, Swierkowski M, Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells 2006;24(4):1030-41
   PubMed Web of Science ®Google Scholar
• Pevsner-Fischer M, Morad V, Cohen-Sfady M, Toll-like receptors and their ligands control mesenchymal stem cell functions. Blood 2007;109:1422-32
   PubMed Web of Science ®Google Scholar
• Quarto R, Mastrogiacomo M, Cancedda R, Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 2001;344:385-6
   PubMed Web of Science ®Google Scholar
• Wakitani S, Imoto K, Yamamoto T, Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthritis Cartilage 2002;10:199-206
   PubMed Web of Science ®Google Scholar
• Charwat S, Gyongyosi M, Lang I, Role of adult bone marrow stem cells in the repair of ischemic myocardium: current state of the art. Exp Hematol 2008;36:672-80
   PubMed Web of Science ®Google Scholar
• Deeg HJ. How I treat refractory acute GVHD. Blood 2007;109:4119-26
   PubMed Web of Science ®Google Scholar
• Ferrara JL, Deeg HJ. Graft-versus-host disease. N Engl J Med 1991;324:667-74
   PubMed Web of Science ®Google Scholar
• Mielcarek M, Martin PJ, Leisenring W, Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. Blood 2003;102:756-62
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Rasmusson I, Sundberg B, Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004;363:1439-41
   PubMed Web of Science ®Google Scholar
• Ringden O, Uzunel M, Rasmusson I, Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 2006;81:1390-7
   PubMed Web of Science ®Google Scholar
• Le Blanc K, Frassoni F, Ball L, Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008;371:1579-86
   PubMed Web of Science ®Google Scholar
• Puissant B, Barreau C, Bourin P, Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br J Haematol 2005;129:118-29
   PubMed Web of Science ®Google Scholar
• Fang B, Song Y, Zhao RC, Using human adipose tissue-derived mesenchymal stem cells as salvage therapy for hepatic graft-versus-host disease resembling acute hepatitis. Transplant Proc 2007;39:1710-13
   PubMed Web of Science ®Google Scholar
• Fang B, Song YP, Liao LM, Treatment of severe therapy-resistant acute graft-versus-host disease with human adipose tissue-derived mesenchymal stem cells. Bone Marrow Transplant 2006;38(5):389-90
   PubMed Web of Science ®Google Scholar
• Lazarus HM, Koc ON, Devine SM, Cotransplantation of HLA-Identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 2005;11:389-98
   PubMed Web of Science ®Google Scholar
• Sudres M, Norol F, Trenado A, Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice. J Immunol 2006;176:7761-7
   PubMed Web of Science ®Google Scholar
• Boulton AJM, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J. The global burden of diabetic foot disease. Lancet 2005;366:1719-24
   PubMed Web of Science ®Google Scholar
• Singer AJ, Clark RAF. Cutaneous wound healing. N Engl J Med 1999;341:738-46
   PubMed Web of Science ®Google Scholar
• Chapel A, Bertho JM, Bensidhoum M, Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome. J Gene Med 2003;5:1028-38
   PubMed Web of Science ®Google Scholar
• Falanga V, Iwamoto S, Chartier M, Autologous bone marrow derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. Tissue Eng 2007;13:1299-312
   PubMedGoogle Scholar
• McFarlin K, Gao X, Liu YB, Bone marrow-derived mesenchymal stromal cells accelerate wound healing in the rat. Wound Repair Regen 2006;14:471-8
   PubMed Web of Science ®Google Scholar
• Wu Y, Chen L, Scott PG, Tredget EE. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 2007;25:2648-59
   PubMed Web of Science ®Google Scholar
• Chen L, Tredget EE, Wu PYG, Wu Y. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS ONE 2008;3(4):e1886
   PubMed Web of Science ®Google Scholar
• Hanson SE, Bentz ML, Hematti P. Mesenchymal stem cell therapy for nonhealing cutaneous wounds. Plast Reconstr Surg 2010;125:510-16
   PubMed Web of Science ®Google Scholar
• Lataillade JJ, Doucet C, Bey E, New approach to radiation burn treatment by dosimetry-guided surgery combined with autologous mesenchymal stem cell therapy. Regen Med 2007;2:785-94
   PubMed Web of Science ®Google Scholar
• Yoshikawa T, Mitsuno H, Nonaka I, Wound therapy by marrow mesenchymal cell transplantation. Plast Reconstr Surg 2008;121:860-77
   PubMed Web of Science ®Google Scholar
• Garcia-Olmo D, Herreros D, Pascual I, Expanded adipose- derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. Dis Colon Rectum 2009;52:79-86
   PubMed Web of Science ®Google Scholar
• Parks AG, Gordon PH, Hardcastle JD. A classifi cation of fistula-in-ano. Br J Surg 1976;63:1-12
   PubMed Web of Science ®Google Scholar
• Whiteford MH, Kilkenny J, Hyman N, Practice parameters for the treatment of perianal abscess and fistula-in-ano (revised). Dis Colon Rectum 2005;48(7):1337-42
   PubMed Web of Science ®Google Scholar
• Garcia-Olmo D, Garcia-Arranz M, Herreros D, A Phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum 2005;48(7):1416-23
   PubMed Web of Science ®Google Scholar
• Present DH, Rutgeerts P, Targan S, Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 1999;340:1398-405
   PubMed Web of Science ®Google Scholar
• Sands BE, Anderson FH, Bernstein CN, Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med 2004;350:8768-85
   Web of Science ®Google Scholar
• Shah K. Neural stem cells and armed derivatives: fate and therapeutic potential in the brain. Gene Ther Reg 2007;3:91-109
   Google Scholar
• Studeny M, Marini FC, Champlin RE, Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res 2002;62:3603-8
   PubMed Web of Science ®Google Scholar
• Power AT, Bell JC. Cell-based delivery of oncolytic viruses: a new strategic alliance for a biological strike against cancer. Mol Ther 2007;15:660-5
   PubMed Web of Science ®Google Scholar
• Komarova S, Kawakami Y, Stoff-Khalili MA, Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses. Mol Cancer Ther 2006;5:755-66
   PubMed Web of Science ®Google Scholar
• Stoff-Khalili M, Rivera A, Mathis J, Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma. Breast Cancer Res Treat 2007;105:157-67
   PubMed Web of Science ®Google Scholar
• Sonabend AM, Ulasov IV, Tyler MA, Mesenchymal stem cells effectively deliver an oncolytic adenovirus to intracranial glioma. Stem Cells 2008;26:831-41
   PubMed Web of Science ®Google Scholar
• Garcia-Castro J, Alemany R, Cascallo M, Treatment of metastatic neuroblastoma with systemic oncolytic virotherapy delivered by autologous mesenchymal stem cells: an exploratory study. Cancer Gene Ther 2010;17:476-83
   PubMed Web of Science ®Google Scholar
• Alonso MM, Cascallo M, Gomez-Manzano C, ICOVIR-5 shows E2F1 addiction and potent antiglioma effect in vivo. Cancer Res 2007;67:8255-63
   PubMed Web of Science ®Google Scholar
• Spees JL, Gregory CA, Singh H, Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. Mol Ther 2004;9:747-56
   PubMed Web of Science ®Google Scholar
• Yu BP, Chung HY. Adaptive mechanisms to oxidative stress during aging. Mech Ageing Dev 2006;127:436-43
   PubMed Web of Science ®Google Scholar
• Romanov SR, Kozakiewicz BK, Holst CR, Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes. Nature 2001;409:633-7
   PubMed Web of Science ®Google Scholar
• Boukamp P, Petrussevska RT, Breitkreutz D, Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 1988;106:761-71
   PubMed Web of Science ®Google Scholar
• Muraglia A, Cancedda R, Quarto R. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 2000;113:1161-6
   PubMed Web of Science ®Google Scholar
• Okamoto T, Aoyama T, Nakayama T, Clonal heterogeneity in differentiation potential of immortalized human mesenchymal stem cells. Biochem Biophys Res Commun 2002;295:354-61
   PubMed Web of Science ®Google Scholar
• Simonsen JL, Rosada C, Serakinci N, Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotech 2002;20:592-6
   PubMed Web of Science ®Google Scholar
• Wang J, Hannon GJ, Beach DH. Cell biology: risky immortalization by telomerase. Nature 2000;405:755-6
   PubMed Web of Science ®Google Scholar
• Kotaro RS, Tomoki A, Yasuko S, Expression of the p16INK4A gene is associated closely with senescence of human mesenchymal stem cells and is potentially silenced by DNA methylation during in vitro expansion. Stem Cells 2007;25:2371-82
   PubMed Web of Science ®Google Scholar
• Dahl JA, Duggal S, Coulston N, Genetic and epigenetic instability of human bone marrow mesenchymal stem cells expanded in autologous serum or fetal bovine serum. Int J Dev Biol 2008;52:1033-42
   PubMed Web of Science ®Google Scholar
• Bochkov NP, Voronina ES, Kosyakova NV, Chromosome variability of human multipotent mesenchymal stromal cells. Bull Exp Biol Med 2007;143:122-6
   PubMed Web of Science ®Google Scholar
• Matushansky I, Hernando E, Socci ND, Derivation of sarcomas from mesenchymal stem cells via inactivation of the Wnt pathway. J Clin Invest 2007;117:3248-57
   PubMed Web of Science ®Google Scholar
• Rubio D, Garcia-Castro J, Martin MC, Spontaneous human adult stem cell transformation. Cancer Res 2005;65:3035-9
   PubMed Web of Science ®Google Scholar
• Rosland GV, Svendsen A, Torsvik A, Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. Cancer Res 2009;69:5331-9
   PubMed Web of Science ®Google Scholar
• Wang Y, Huso DI, Harrington J, Outgrowth of a transformed cell population derived from normal human BM mesenchymal stem cell culture. Cytotherapy 2005;7:509-19
   PubMed Web of Science ®Google Scholar
• Bernardo ME, Zaffaroni N, Novara F, Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res 2007;67:9142-9
   PubMed Web of Science ®Google Scholar
• Grimes BR, Steiner CM, Merfeld-Clauss S, Interphase FISH demonstrates that human adipose stromal cells maintain a high level of genomic stability in long-term culture. Stem Cells Dev 2009;18:717-24
   PubMed Web of Science ®Google Scholar
• Kim J, Kang J, Park J, Biological characterization of long-term cultured human mesenchymal stem cells. Arch Pharm Res 2009;32:117-26
   PubMed Web of Science ®Google Scholar
• Garcia S, Martin MC, de la Fuente R, Pitfalls in spontaneous in vitro transformation of human mesenchymal stem cells. Exp Cell Res 2010;316:1648-50
   PubMed Web of Science ®Google Scholar
• Allison M. Genzyme backs Osiris, despite Prochymal flop. Nat Biotech 2009;27(11):966-7
   PubMed Web of Science ®Google Scholar
• Prochymal™ Adult Human Mesenchymal Stem Cells for Treatment of Moderate-to-severe Crohn's Disease. Washington, DC: FDA, ClinicalTrials.gov, 2006. Available from: http://www.clinicaltrials.gov/ct2/show/NCT00294112?term=NCT00294112&rank=1 [Last accessed 27 August 2010]
   Google Scholar
• Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection:a Phase I-II clinical trial. Washington, DC: FDA, ClinicalTrials.gov, 2007. Available from: http://www.clinicaltrials.gov/ct2/show/NCT00420134?term=NCT00420134&rank=1 [Last accessed 27 August 2010]
   Google Scholar
• Safety and efficacy study of adult human mesenchymal stem cells to treat acute GVHD. Washington, DC: FDA, ClinicalTrials.gov, 2005. Available from: http://www.clinicaltrials.gov/ct2/show/NCT00136903?term=NCT00136903&rank=1 [Last accessed 27 August 2010]
   Google Scholar
• Extended evaluation of Prochymal adult human stem cells for treatment-resistant moderate-to-severe Crohn's disease. Washington, DC: FDA, ClinicalTrials.gov, 2007. Available from: http://www.clinicaltrials.gov/ct2/show/NCT00543374?term=NCT00543374&rank=1 [Last accessed 27 August 2010]
   Google Scholar
• Efficacy and safety of adult human mesenchymal stem cells to treat patients who have failed to respond to steroid treatment for acute graft versus host disease (GVHD). Washington, DC: FDA, ClinicalTrials.gov, 2006. Available from: http://www.clinicaltrials.gov/ct2/show/NCT00366145?term=NCT00366145&rank=1 [Last accessed 27 August 2010]
   Google Scholar
• Bone marrow stem cells as a source of allogenic hepatocyte transplantation in homozygous familial hypercholesterolemia. Washington, DC: FDA, ClinicalTrials.gov, 2007. Available from: http://www.clinicaltrials.gov/ct2/show/NCT00515307?term=NCT00515307&rank=1 [Last accessed 27 August 2010]
   Google Scholar
• A Phase I/II study of chondrogen delivered by intra-articular injection following meniscectomy. Washington, DC: FDA, ClinicalTrials.gov, 2005. Available from: http://www.clinicaltrials.gov/ct2/show/NCT00225095?term=NCT00225095&rank=1 [Last accessed 27 August 2010]
   Google Scholar
• Clinical trials of regeneration for periodontal tissue. Washington, DC: FDA, ClinicalTrials.gov, 2005. Available from: http://www.clinicaltrials.gov/ct2/show/NCT00221130?term=NCT00221130&rank=1 [Last accessed 27 August 2010]
   Google Scholar
• Safety and efficacy of Prochymal for the salvage of treatment-refractory acute GVHD patients Washington, DC: FDA, ClinicalTrials.gov, 2006. Available from: http://www.clinicaltrials.gov/ct2/show/NCT00284986?term=NCT00284986&rank=1 [Last accessed 27 August 2010]
   Google Scholar
• Stem cell therapy for vasculogenesis in patients with severe myocardial ischemia. Washington, DC: FDA, ClinicalTrials.gov, 2005. Available from: http://www.clinicaltrials.gov/ct2/show/NCT00260338?term=NCT00260338&rank=1 [Last accessed 27 August 2010]
   Google Scholar
• Induced wound healing by application of expanded bone marrow stem cells in diabetic patients with critical limb ischemia. Washington, DC: FDA, ClinicalTrials.gov, 2010. Available from: http://www.clinicaltrials.gov/ct2/show/NCT01065337?term=NCT01065337&rank=1 [Last accessed 27 August 2010]
   Google Scholar
• Efficacy and safety of adipose stem cells to treat complex perianal fistulas not associated to Crohn's disease. Washington, DC: FDA, ClinicalTrials.gov, 2007. Available from: http://www.clinicaltrials.gov/ct2/show/NCT00475410?term=NCT00475410&rank=1 [Last accessed 27 August 2010]
   Google Scholar
• Safety and efficacy of autologous cultured adipocytes in patient with depressed scar. Washington, DC: FDA, ClinicalTrials.gov, 2009. Available from: http://www.clinicaltrials.gov/ct2/show/NCT00992147?term=NCT00992147&rank=1 [Last accessed 27 August 2010]
   Google Scholar